CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease
about
Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Diseaseα-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.Narrative Organization Deficit in Lewy Body Disorders Is Related to Alzheimer Pathology.An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementiasLatent Cognitive Phenotypes in De Novo Parkinson's Disease: A Person-Centered Approach.Cognitive decline in Parkinson disease.Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias.Changes of cerebrospinal fluid Aβ42, t-tau, and p-tau in Parkinson's disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Serotonin, beta-amyloid, and cognition in Parkinson disease.Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease.CSF Aβ level is associated with cognitive decline in early Parkinson's disease with rapid eye movement sleep behavior disorder
P2860
Q26744782-E643C4BD-6D3F-479C-ACF6-48841218967CQ36277049-9D1AA534-BFE4-4B87-885C-B135DF1CD407Q37494873-CA76B0F4-6212-4961-BADC-615636630B36Q37629836-7E48357E-185C-4D68-9E7E-F345CA01CC3BQ38628562-1FD24E77-070A-427D-A773-F3DFE7E39D98Q38708401-7FA03DF3-58AF-4AA5-B7E4-E238F847511CQ38751099-DE9B9649-E3AD-4501-BE07-2786BA272F62Q38853776-62A09F39-0A2C-42E0-B3D7-FF889D974391Q39149219-2576064F-CC1B-4DCC-B52A-B38241FD0C8DQ39170813-27FF259F-EAEF-4944-9196-C1E19623EE07Q39366291-5A03DE1A-5253-4673-AC05-ACB57FEFB7BAQ45945368-1B9F2FFD-9D5C-4EA9-8D58-E51406C1B758Q47571451-05244B3F-D88B-4D07-9F85-749745A59D47Q47923287-31D87EAF-3904-4582-84D2-D62C36451F21Q48238518-B7CAD78A-603A-4AB0-81F2-6C3AEDF8C8B8Q49987358-DC4D4AB1-2707-4FC9-810C-0690F7B066C5Q52582953-DC861D0B-CDFB-47AB-B319-FC5747F0EA41Q53397478-BAC299D3-A178-47C4-A584-B6E7D2BAB04AQ58580982-B9B2CD40-7EB0-4254-94CC-D4F5B9CE47DD
P2860
CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CSF β-Amyloid 1-42 Predicts Pr ...... ly Diagnosed Parkinson Disease
@ast
CSF β-Amyloid 1-42 Predicts Pr ...... ly Diagnosed Parkinson Disease
@en
type
label
CSF β-Amyloid 1-42 Predicts Pr ...... ly Diagnosed Parkinson Disease
@ast
CSF β-Amyloid 1-42 Predicts Pr ...... ly Diagnosed Parkinson Disease
@en
prefLabel
CSF β-Amyloid 1-42 Predicts Pr ...... ly Diagnosed Parkinson Disease
@ast
CSF β-Amyloid 1-42 Predicts Pr ...... ly Diagnosed Parkinson Disease
@en
P2093
P2860
P1476
CSF β-Amyloid 1-42 Predicts Pr ...... ly Diagnosed Parkinson Disease
@en
P2093
Karen S Marder
Mark Terrelonge
Roy N Alcalay
P2860
P2888
P356
10.1007/S12031-015-0647-X
P577
2015-09-02T00:00:00Z